Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.39 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TBXAS1 | P24557 | 5/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2467911 | 0.86 | BLM (0.42) | EPHX2BLMTSHRGABRR1GABRR2 | |
| SCHEMBL6635415 | 0.79 | APP (0.44) | EPHX2BLMLMNAAPPPTGS1 | |
| Potassium Ion SCHEMBL6063239 | 0.79 | CA1 (0.52) | EPHX2BLMLMNAAPPPTGS1 | |
| SCHEMBL31563774 | 0.79 | EPHX2 (0.54) | EPHX2BLMLMNAAPEX1NPSR1 | |
| SCHEMBL8590318 | 0.78 | TSHR (0.52) | BLMTSHRGABRR1GABRR2LMNA | |
| SCHEMBL8590317 | 0.78 | TSHR (0.52) | BLMTSHRGABRR1GABRR2LMNA | |
| SCHEMBL1942738 | 0.78 | TSHR (0.52) | BLMTSHRGABRR1GABRR2LMNA | |
| SCHEMBL1942740 | 0.78 | TSHR (0.52) | BLMTSHRGABRR1GABRR2LMNA | |
| SCHEMBL5428688 | 0.76 | CHRNB2 (0.42) | EPHX2APP | |
| SCHEMBL7856305 | 0.76 | PTPN1 (0.52) | BLMTSHRGABRR1GABRR2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108472505-A | The method removed for spore | 3M创新有限公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-108471757-A | Method for removing spores | 3M创新有限公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-102604752-B | Use and application of defined zwitterionic copolymer | PROCTER & GAMBLE | 2015-01-28 | — | — | CN | disclosed |
| US-8808678-B2 | Use and application of defined zwitterionic copolymer | THE PROCTER & GAMBLE COMPANY (US) | 2014-08-19 | — | — | US | disclosed |
| US-20140047653-A1 | USE AND APPLICATION OF DEFINED ZWITTERIONIC COPOLYMER | THE PROCTER & GAMBLE COMPANY (US) | 2014-02-20 | — | — | US | disclosed |
| US-8568702-B2 | Use and application of defined zwitterionic copolymer | THE PROCTER & GAMBLE COMPANY (US) | 2013-10-29 | — | — | US | disclosed |
| EP-2287214-B1 | Use and application of defined zwitterionic copolymer | PROCTER & GAMBLE (US) | 2012-07-25 | — | — | EP | disclosed |
| US-20110197382-A1 | Use And Application Of Defined Zwitterionic Copolymer | SHERRY ALAN EDWARD | 2011-08-18 | — | — | US | disclosed |
| EP-2287214-A1 | Use and application of defined zwitterionic copolymer | The Procter & Gamble Company (US) | 2011-02-23 | — | — | EP | disclosed |
| EP-1687348-B1 | COPOLYMERS COMPRISING POLYALKYLENE OXIDE GROUPS AND QUATERNARY NITROGEN ATOMS | BASF SE (DE) | 2008-11-12 | — | — | EP | disclosed |
| EP-1948702-A2 | USE AND APPLICATION OF DEFINED ZWITTERIONIC COPOLYMER | The Procter and Gamble Company (US) | 2008-07-30 | — | — | EP | disclosed |
| WO-2007057865-A2 | USE AND APPLICATION OF DEFINED ZWITTERIONIC COPOLYMER | THE PROCTER & GAMBLE COMPANY (US) | 2007-05-24 | — | — | WO | disclosed |
| US-20070110699-A1 | Use and application of defined zwitterionic copolymer | PROCTER & GAMBLE COMPANY, THE | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070110699-A1 | Use and application of defined zwitterionic copolymer | CHRM1, CHRM2, C1S | EPHX2 26/4885BLM 856/4885TSHR 3825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.